American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
Lowell E. Schnipper(Sidney Kimmel Cancer Center), Richard L. Schilsky(Dana-Farber Brigham Cancer Center), Therese M. Mulvey(Sidney Kimmel Cancer Center), Dana S. Wollins(Institute of Cancer Research), Leonard B. Saltz(Roswell Park Comprehensive Cancer Center), Nancy E. Davidson(Johns Hopkins University), Clifford A. Hudis(Memorial Sloan Kettering Cancer Center), Adam P. Dicker(Thomas Jefferson University), Neal J. Meropol(Sidney Kimmel Cancer Center), Thomas J. Smith(Sidney Kimmel Comprehensive Cancer Center), Lee N. Newcomer(Sidney Kimmel Cancer Center), Derek Raghavan(University of Southern California), Douglas W. Blayney(Sidney Kimmel Cancer Center), Blasé N. Polite(Sidney Kimmel Cancer Center), Gary H. Lyman(University of Washington), Courtney Tyne(Memorial Sloan Kettering Cancer Center), J. Russell Hoverman(Texas Oncology), Deborah Schrag(Memorial Sloan Kettering Cancer Center), Peter Paul Yu(Sidney Kimmel Cancer Center), Patricia A. Ganz(University of California, Los Angeles), Gregory Rossi(Sidney Kimmel Cancer Center), Jeffrey Peppercorn(Durham University), Diane Blum(Sidney Kimmel Cancer Center), Robert M. Langdon(Sidney Kimmel Cancer Center)
Cited by 903
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k